Seroatlas · Human Serome Atlas

IRF6

Interferon regulatory factor 6

Also known as: IRF6_HUMAN, LPS, OFC6, VWS, VWS1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O14896
Gene
IRF6
Ensembl
ENSG00000117595
Chromosome
1
Canonical length
467 aa
Protein class
Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
Subcellular location
Nucleoplasm,Cytosol

OverviewNCBI Gene

This gene encodes a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. The encoded protein may be a transcriptional activator. Mutations in this gene can cause van der Woude syndrome and popliteal pterygium syndrome. Mutations in this gene are also associated with non-syndromic orofacial cleft type 6. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2011]

Canonical amino-acid sequenceUniProt

467 residues, UniProt reviewed canonical sequence.

>O14896|IRF6
     1  MALHPRRVRL KPWLVAQVDS GLYPGLIWLH RDSKRFQIPW KHATRHSPQQ EEENTIFKAW
    61  AVETGKYQEG VDDPDPAKWK AQLRCALNKS REFNLMYDGT KEVPMNPVKI YQVCDIPQPQ
   121  GSIINPGSTG SAPWDEKDND VDEEDEEDEL DQSQHHVPIQ DTFPFLNING SPMAPASVGN
   181  CSVGNCSPEA VWPKTEPLEM EVPQAPIQPF YSSPELWISS LPMTDLDIKF QYRGKEYGQT
   241  MTVSNPQGCR LFYGDLGPMP DQEELFGPVS LEQVKFPGPE HITNEKQKLF TSKLLDVMDR
   301  GLILEVSGHA IYAIRLCQCK VYWSGPCAPS LVAPNLIERQ KKVKLFCLET FLSDLIAHQK
   361  GQIEKQPPFE IYLCFGEEWP DGKPLERKLI LVQVIPVVAR MIYEMFSGDF TRSFDSGSVR
   421  LQISTPDIKD NIVAQLKQLY RILQTQESWQ PMQPTPSMQL PPALPPQ

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IRF6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.43
Highest tissue expression
104 nTPM

Expression across tissuesHPA

Tissue

  • skin: 104 nTPM
  • esophagus: 87 nTPM
  • vagina: 44 nTPM
  • epididymis: 44 nTPM
  • urinary bladder: 35 nTPM
  • salivary gland: 35 nTPM

Single-cell type

  • papillary tip epithelial cells: 40 nCPM
  • renal collecting duct intercalated cells: 26 nCPM
  • distal convoluted tubule cells: 17 nCPM
  • renal collecting duct principal cells: 15 nCPM
  • renal connecting tubule cells: 14 nCPM
  • loop of henle epithelial cells: 8.7 nCPM

Immune cell

  • eosinophil: 0.4 nTPM
  • gdT-cell: 0.4 nTPM
  • MAIT T-cell: 0.3 nTPM
  • naive CD4 T-cell: 0.3 nTPM
  • intermediate monocyte: 0.2 nTPM
  • naive CD8 T-cell: 0.2 nTPM

Brain region

  • cerebellum: 20 nTPM
  • choroid plexus: 9.6 nTPM
  • midbrain: 5 nTPM
  • hypothalamus: 3.9 nTPM
  • spinal cord: 3.8 nTPM
  • medulla oblongata: 3.4 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about IRF6.

Disease | AllUniProt

Conditions IRF6 is implicated in, by any mechanism.

Disease | GeneticClinVar

131 pathogenic / likely-pathogenic of 388 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.13
gnomAD pLI
1
gnomAD missense Z
2.74
DepMap mean gene effect
-0.05
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of IRF6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IRF6 as an antibody target. Whether an autoantibody or antibody against IRF6 could matter depends on whether native IRF6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IRF6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label IRF6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IRF6. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...